PARTNER NEWS:Tue, May 7, 12:15 PM, Zacks
Select Medical's (SEM) Shares Up 12.9% Since Q1 Earnings Beat
Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.
Tue, May 7, 4:20 AM, Zacks
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Sector ETF report for RSPH